Pura Vida Investments, LLC Gossamer Bio, Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $1.88 Million - $3.88 Million	261,000 Added 322.71%	341,878 $4.1 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $42,094 - $70,298	-7,051 Reduced 8.02%	80,878 $677,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $4,220 - $6,245	500 Added 0.57%	87,929 $763,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $26,797 - $37,257	-2,648 Reduced 2.94%	87,429 $989,000
Q3 2021 Nov 15, 2021	SELL	$7.25 - $13.23 $62,031 - $113,195	-8,556 Reduced 8.67%	90,077 $1.13 Million
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $12,968 - $15,804	-1,621 Reduced 1.62%	98,633 $801,000
Q1 2021 May 12, 2021	BUY	$8.63 - $10.94 $865,192 - $1.1 Million	100,254 New	100,254 $927,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.